Polomar Health Services, Inc.

The Company operates Polomar Specialty Pharmacy, LLC, a State of Florida licensed retail compounding pharmacy located in Palm Harbor, FL, under license # PH35196. Polomar Pharmacy also holds a Special Sterile Compounding Pharmacy permit, #PH35277, which allows it to dispense injectable and other sterile compounds like eye drops and infused therapeutics upon receiving a valid prescription. The compounding facility adheres to guidelines under Section 503A "Compounding Pharmacy" of the Federal Food, Drug and Cosmetic Act, which authorizes it to manufacture compounded drugs and fulfill prescriptions from state-licensed physicians and other healthcare professionals, including physician assistants and nurse practitioners. The Company is currently licensed and authorized to fulfill and deliver compounded prescribed medications in 28 states. Prior to the September 30, 2024 merger between the Company and Polomar Pharmacy, Polomar Pharmacy focused on compounded dermatological prescription medications for topical delivery. Its exclusive dermatological formulations, co-developed by a board-certified dermatologist, treated conditions such as acne, alopecia areata, basal cell carcinoma, Becker's nevus, and vitiligo. These were primarily fulfilled for local dermatologists with limited interstate prescription delivery. In early 2024, Polomar Pharmacy began constructing clean rooms for dispensing sterile compounded drugs, receiving its Special Sterile Compounding Permit in August of 2024. While continuing to primarily fulfill dermatological drug prescriptions, it has also, on a limited basis, fulfilled prescriptions for sterile compounded GLP-1 agonists for subcutaneous injection. On September 26, 2025, the Company executed a one-year non-exclusive pharmacy services agreement with CareValidate, Inc. to fulfill GLP-1 agonist prescriptions for CareValidate's network of on-line clinics.